Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthrax vaccines.

A M Friedlander1, S L Welkos, B E Ivins

  • 1U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Frederick, MD 21702, USA. friedlander@amedd.army.mil

Current Topics in Microbiology and Immunology
|September 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences.

PloS one·2019
Same author

Incorporating germination-induction into decontamination strategies for bacterial spores.

Journal of applied microbiology·2017
Same author

Comparison of sampling methods to recover germinated Bacillus anthracis and Bacillus thuringiensis endospores from surface coupons.

Journal of applied microbiology·2017
Same author

Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences.

PloS one·2017
Same author

Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice.

Archives of microbiology·2016
Same author

Reproductive life history of the introduced peacock grouper Cephalopholis argus in Hawaii.

Journal of fish biology·2016
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
See all related articles

New anthrax vaccines are crucial for human protection against bioterrorism. This review covers recent advancements in protein, live attenuated, and genetic anthrax vaccines.

Area of Science:

  • Vaccinology
  • Microbiology
  • Biodefense

Background:

  • Anthrax vaccines are primarily developed to counter intentional Bacillus anthracis (anthrax) use as a bioweapon.
  • Early anthrax vaccines were live attenuated versions for livestock, followed by nonliving component vaccines.
  • Licensed protein-based anthrax vaccines for humans emerged in the 1970s.

Purpose of the Study:

  • To review recent scientific progress in the development of novel anthrax vaccines.
  • To explore advancements in protein-based, live attenuated, and genetic vaccine technologies for anthrax.
  • To highlight the ongoing efforts in creating effective countermeasures against anthrax as a bioterrorism threat.

Main Methods:

  • Review of recent scientific literature and research on anthrax vaccine development.

Related Experiment Videos

  • Analysis of advancements in protein, live attenuated, and genetic vaccine platforms.
  • Synthesis of current knowledge on vaccine efficacy and safety for Bacillus anthracis.

    • Main Results:

    • Significant progress has been made in developing diverse anthrax vaccine candidates.
    • Protein-based, live attenuated, and genetic approaches show promise for improved anthrax protection.
    • Current research focuses on enhancing vaccine efficacy and broadening protection against Bacillus anthracis.

    Conclusions:

    • Continued innovation in vaccine technology is essential for addressing the threat of anthrax.
    • Multiple vaccine strategies are being pursued to ensure robust human immunity against anthrax.
    • Future vaccines aim to provide superior protection against intentional Bacillus anthracis exposure.